News
At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.
Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...
(Reuters) - Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health ...
(Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los Angeles ...
When it comes to comfort and productivity, the right ergonomic mouse pad can make a big difference, especially for men who spend long hours working or gaming at their desks. An ergonomic mouse pad ...
A class-action lawsuit claims Merck overcharged for a less potent mumps vaccine, violating the Sherman Act. The District Court denied Merck's summary judgment, acknowledging ethical issues but ...
Merck’s (NYSE:MRK) human papillomavirus (HPV) vaccine Gardasil 9 has met key efficacy goals in a pivotal late-stage trial involving Japanese males ages 16 to 26 years. The Phase 3 V503-064 trial ...
More than 300,000 people received the vaccine during the 2018 DRC outbreak via the ring vaccination approach, including pregnant women and infants. That outbreak had a fatality rate of 66%, with ...
So it's a good idea to clean your mouse pad now and again — it not only looks better but it's more hygienic, too. Here's how to clean your mouse pad to get it back to near-new condition.
Merck (NYSE:MRK) has received FDA approval for its Capvaxive 21-valent conjugate vaccine for the prevention of pneumonia in adults. The drugmaker said the vaccine is designed to cover serotypes ...
Merck's pneumococcal vaccine could become available later this summer The U.S. Food and Drug Administration (FDA) approved Merck & Co Inc's (NYSE:MRK) next-generation vaccine to protect adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results